Emergence of chronic Lyme arthritis: Putting the breaks on CD28 costimulation

References

• Steere, A.C.; Coburn, J.; Glickstein, L. The emergence of Lyme disease. J Clin Invest. 2004, 113 (8):1093–1101.
   PubMedGoogle Scholar
• Steere, A.C. Lyme disease. N Engl J. Med. 2001, 345 (2):115–125.
   PubMedGoogle Scholar
• Coburn, J.R.A.K. Lyme Disease. Encyclopedia Microbiol. 2000, 3:109–130.
   Google Scholar
• Hu, L. Lyme arthritis. Infect Dis Clin North Am. 2005, 19 (4):947–961.
   PubMedGoogle Scholar
• Steere, A.C.; Schoen, R.T.; Taylor, E. The clinical evolution of Lyme arthritis. Ann Intern Med. 1987, 107 (5):725–731.
   PubMedGoogle Scholar
• Steere, A.C.; Malawista, S.E.; Hardin, J.A.; Ruddy, S.; Askenase, W.; Andiman, W.A. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med. 1977, 86 (6):685–698.
   PubMedGoogle Scholar
• Nocton, J.J.; Dressler, F.; Rutledge, B.J.; Rys, P.N.; Persing, D.H.; Steere, A.C. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med. 1994, 330 (4):229–234.
   PubMedGoogle Scholar
• Iliopoulou, B.P.; Alroy, J.; Huber, B.T. CD28 deficiency exacerbates joint inflammation upon borrelia burgdorferi infection, resulting in the development of chronic Lyme arthritis. J Immunol. 2007, 179 (12):8076–8082.
   PubMedGoogle Scholar
• Barthold, S.W.; de Souza, M.S.; Janotka, J.L.; Smith, A.L.; Persing, D.H. Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol. 1993, 143 (3):959–971.
   PubMedGoogle Scholar
• Barthold, S.W.; Persing, D.H.; Armstrong, A.L.; Peeples, R.A. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am J Pathol. 1991, 139 (2):263–273.
   PubMedGoogle Scholar
• Barthold, S.W.; Beck, D.S.; Hansen, G.M.; Terwilliger, G.A.; Moody, K.D. Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis. 1990, 162 (1):133–138.
   PubMedGoogle Scholar
• Ma, Y.; Seiler, K.P.; Eichwald, E.J.; Weis, J.H.; Teuscher, C.; Weis, J.J. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immunol. 1998, 66 (1):161–168.
   PubMedGoogle Scholar
• Wooten, R.M.; Weis, J.J. Host-pathogen interactions promoting inflammatory Lyme arthritis: Use of mouse models for dissection of disease processes. Curr Opin Microbiol. 2001, 4 (3):274–279.
   PubMedGoogle Scholar
• Mills, K.H. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol. 2004, 4 (11):841–855.
   PubMedGoogle Scholar
• Dennis, V.A.; Jefferson, A.; Singh, S.R.; Ganapamo, F.; Philipp, M.T. Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: A possible role for suppressors of cytokine signaling 1 and 3. Infect Immunol. 2006, 74 (10):5780–5789.
   PubMedGoogle Scholar
• Brown, J.P.; Zachary, J.F.; Teuscher, C.; Weis, J.J.; Wooten, R.M. Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect Immunol. 1999, 67 (10):5142–5150.
   PubMedGoogle Scholar
• Giambartolomei, G.H.; Dennis, V.A.; Lasater, B.L.; Murthy, P.K.; Philipp, M.T. Autocrine and exocrine regulation of interleukin-10 production in THP-1 cells stimulated with Borrelia burgdorferi lipoproteins. Infect Immunol. 2002, 70 (4):1881–1888.
   PubMedGoogle Scholar
• Giambartolomei, G.H.; Dennis, V.A.; Lasater, B.L.; Philipp, M.T. Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect Immunol. 1999, 67 (1):140–147.
   PubMedGoogle Scholar
• Giambartolomei, G.H.; Dennis, V.A.; Philipp, M.T. Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys. Infect Immunol. 1998, 66 (6):2691–2697.
   PubMedGoogle Scholar
• Lazarus, J.J.; Meadows, M.J.; Lintner, R.E.; Wooten, R.M. IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J Immunol. 2006, 177 (10):7076–7085.
   PubMedGoogle Scholar
• Lisinski, T.J.; Furie, M.B. Interleukin-10 inhibits proinflammatory activation of endothelium in response to Borrelia burgdorferi or lipopolysaccharide but not interleukin-1beta or tumor necrosis factor alpha. J Leukoc Biol. 2002, 72 (3):503–511.
   PubMedGoogle Scholar
• Murthy, P.K.; Dennis, V.A.; Lasater, B.L.; Philipp, M.T. Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins. Infect Immunol. 2000, 68 (12):6663–6669.
   PubMedGoogle Scholar
• Yin, Z.; Braun, J.; Neure, L.; Wu, P.; Eggens, U.; Krause, A.; Kamradt, T.; Sieper, J.T. cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum. 1997, 40 (1):69–79.
   PubMedGoogle Scholar
• Pohl-Koppe, A.; Balashov, K.E.; Steere, A.C.; Logigian, E.L.; Hafler, D.A. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J Immunol. 1998, 160 (4):1804–1810.
   PubMedGoogle Scholar
• Sharpe, A.H.; Freeman, G.J. The B7-CD28 superfamily. Nat Rev Immunol. 2002, 2 (2):116–126.
   PubMedGoogle Scholar
• Bour-Jordan, H.; Blueston, J. A. CD28 function: A balance of costimulatory and regulatory signals. J Clin Immunol. 2002, 22 (1):1–7.
   PubMedGoogle Scholar
• Shahinian, A.; Pfeffer, K.; Lee, K.P.; Kundig, T.M.; Kishihara, K.; Wakeham, A.; Kawai, K.; Ohashi, P.S.; Thompson, C.B.; Mak, T.W. Differential T cell costimulatory requirements in CD28-deficient mice. Science. 1993, 261 (5121):609–612.
   PubMedGoogle Scholar
• Keir, M.E.; Sharpe, A.H. The B7/CD28 costimulatory family in autoimmunity. Immunol Rev. 2005, 204:128–143.
   PubMed Web of Science ®Google Scholar
• Tang, Q.; Henriksen, K.J.; Boden, E.K.; Tooley, A.J.; Ye, J.; Subudhi, S.K.; Zheng, X.X.; Strom, T.B.; Bluestone, J.A. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol. 2003, 171 (7):3348–3352.
   PubMedGoogle Scholar
• Salomon, B.; Lenschow, D.J.; Rhee, L.; Ashourian, N.; Singh, B.; Sharpe, A.; Bluestone, J.A. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 2000, 12 (4):431–440.
   PubMedGoogle Scholar
• Compton, H.L.; Farrell, J.P. CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major. J Immunol. 2002, 168 (3):1302–1308.
   PubMedGoogle Scholar
• Rafiq, K.; Charitidou, L.; Bullens, D.M.; Kasran, A.; Lorre, K.; Ceuppens, J.; van Gool, S.W. Regulation of the IL-10 production by human T cells. Scand. J Immunol. 2001, 53 (2):139–147.
   Google Scholar
• Okamoto, N.; Tezuka, K.; Kato, M.; Abe, R.; Tsuji, T. PI3-kinase and MAP-kinase signaling cascades in AILIM/ICOS- and CD28-costimulated T-cells have distinct functions between cell proliferation and IL-10 production. Biochem Biophys Res Commun. 2003, 310 (3):691–702.
   PubMedGoogle Scholar
• Mittrucker, H.W.; Kohler, A.; Mak, T.W.; Kaufmann, S.H. Critical role of CD28 in protective immunity against Salmonella typhimurium. J Immunol. 1999, 163 (12):6769–6776.
   PubMedGoogle Scholar
• Martins, G.A.; Campanelli, A.P.; Silva, R.B.; Tadokoro, C.E.; Russo, M.; Cunha, F.Q.; Rizzo, L.V.; Silva, J.S. CD28 is required for T cell activation and IFN-gamma production by CD4+ and CD8+ T cells in response to Trypanosoma cruzi infection. Microbes Infect. 2004, 6 (13):1133–1144.
   PubMedGoogle Scholar
• Marks, E.; Verolin, M.; Stensson, A.; Lycke, N. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection. Infect Immunol. 2007, 75 (9):4638–4647.
   PubMedGoogle Scholar
• Honstettre, A.; Meghari, S.; Nunes, J.A.; Lepidi, H.; Raoult, D.; Olive, D.; Mege, J.L. Role for the CD28 molecule in the control of Coxiella burnetii infection. Infect Immunol. 2006, 74 (3):1800–1808.
   PubMedGoogle Scholar
• Gause, W.C.; Chen, S.J.; Greenwald, R.J.; Halvorson, M.J.; Lu, P.; Zhou, X.D.; Morris, S.C.; Lee, K.P.; June, C.H.; Finkelman, F.D.; Urban, J.F.; Abe, R. CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J Immunol. 1997, 158 (9):4082–4087.
   PubMedGoogle Scholar
• Kopf, M.; Coyle, A.J.; Schmitz, N.; Barner, M.; Oxenius, A.; Gallimore, A.; Gutierrez-Ramos, J.C.; Bachmann, M.F. Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J Exp Med. 2000, 192 (1):53–61.
   PubMedGoogle Scholar
• Hogan, L.H.; Markofski, W.; Bock, A.; Barger, B.; Morrissey, J.D.; Sandor, M. Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28. Infect Immunol. 2001, 69 (4):2596–2603.
   PubMedGoogle Scholar
• Rummel, T.; Batchelder, J.; Flaherty, P.; LaFleur, G.; Nanavati, P.; Burns, J.M.; Weidanz, W.P. CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against blood-stage Plasmodium chabaudi malaria parasites. Infect Immunol. 2004, 72 (10):5768–5774.
   PubMedGoogle Scholar
• Villegas, E.N.; Elloso, M.M.; Reichmann, G.; Peach, R.; Hunter, C.A. Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii. J Immunol. 1999, 163 (6):3344–3353.
   PubMedGoogle Scholar
• Mittrucker, H.W.; Kursar, M.; Kohler, A.; Hurwitz, R.; Kaufmann, S.H. Role of CD28 for the generation and expansion of antigen-specific CD8(+) T lymphocytes during infection with Listeria monocytogenes. J Immunol. 2001, 167 (10):5620–5627.
   PubMedGoogle Scholar
• Brown, D.R.; Green, J.M.; Moskowitz, N.H.; Davis, M.; Thompson, C.B.; Reiner, S.L. Limited role of CD28-mediated signals in T helper subset differentiation. J Exp Med. 1996, 184 (3):803–810.
   PubMedGoogle Scholar
• Shanafelt, M.C.; Kang, I.; Barthold, S.W.; Bockenstedt, L.K. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway. Infect Immunol. 1998, 66 (1):266–271.
   PubMedGoogle Scholar
• Acuto, O.; Michel, F. CD28-mediated co-stimulation: A quantitative support for TCR signalling. Nat Rev Immunol. 2003, 3 (12):939–951.
   PubMedGoogle Scholar
• Villegas, E.N.; Lieberman, L.A.; Mason, N.; Blass, S.L.; Zediak, V.P.; Peach, R.; Horan, T.; Yoshinaga, S.; Hunter, C.A. A role for inducible costimulator protein in the CD28-independent mechanism of resistance to Toxoplasma gondii. J Immunol. 2002, 169 (2):937–943.
   PubMedGoogle Scholar
• Anguita, J.; Roth, R.; Samanta, S.; Gee, R.J.; Barthold, S.W.; Mamula, M.; Fikrig, E. B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis. Infect Immunol. 1997, 65 (8):3037–3041.
   PubMedGoogle Scholar
• Pal, U.; de Silva, A.M.; Montgomery, R.R.; Fish, D.; Anguita, J.; Anderson, J.F.; Lobet, Y.; Fikrig, E. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein. AJ Clin Invest. 2000, 106 (4):561–569.
   PubMedGoogle Scholar
• Akin, E.; McHugh, G.L.; Flavell, R.A.; Fikrig, E.; Steere, A.C. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immunol. 1999, 67 (1):173–181.
   PubMedGoogle Scholar
• Fikrig, E.; Feng, W.; Aversa, J.; Schoen, R.T.; Flavell, R.A. Differential expression of Borrelia burgdorferi genes during erythema migrans and Lyme arthritis. J Infect Dis. 1998, 178 (4):1198–1201.
   PubMedGoogle Scholar
• Vaz, A.; Glickstein, L.; Field, J.A.; McHugh, G.; Sikand, V.K.; Damle, N.; Steere, A.C. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect Immunol. 2001, 69 (12):7437–7444.
   PubMedGoogle Scholar
• Kalish, R.A.; Leong, J.M.; Steere, A.C. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect Immunol. 1995, 63 (6):2228–2235.
   PubMedGoogle Scholar
• Crowley, H.; Huber, B.T. Host-adapted Borrelia burgdorferi in mice expresses OspA during inflammation. Infect Immunol. 2003, 71 (7):4003–4010.
   PubMedGoogle Scholar
• Ma, Y.; Weis, J.J. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immunol. 1993, 61 (9):3843–3853.
   PubMedGoogle Scholar
• Weis, J.J.; Ma, Y.; Erdile, L.F. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: Dependence on lipid modification. Infect Immunol. 1994, 62 (10):4632–4636.
   PubMedGoogle Scholar
• Fikrig, E.; Barthold, S.W.; Chen, M.; Chang, C.H.; Flavell, R.A. Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells. J Immunol. 1997, 159 (11):5682–5686.
   PubMedGoogle Scholar
• Fikrig, E.; Barthold, S.W.; Chen, M.; Grewal, I.S.; Craft, J.; Flavell, R.A. Protective antibodies in murine Lyme disease arise independently of CD40 ligand. J Immunol. 1996, 157 (1):1–3.
   PubMedGoogle Scholar
• McKisic, M.D.; Barthold, S.W. T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of Lyme disease. Infect Immunol. 2000, 68 (9):5190–5197.
   PubMedGoogle Scholar
• Crandall, H.; Dunn, D.M.; Ma, Y.; Wooten, R.M.; Zachary, J.F.; Weis, J.H.; Weiss, R.B.; Weis, J.J. Gene expression profiling reveals unique pathways associated with differential severity of Lyme arthritis. J Immunol. 2006, 177 (11):7930–7942.
   PubMedGoogle Scholar
• Gross, D.M.; Forsthuber, T.; Tary-Lehmann, M.; Etling, C.; Ito, K.; Nagy, Z.A.; Field, J.A.; Steere, A.C.; Huber, B.T. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science. 1998, 281 (5377):703–706.
   PubMedGoogle Scholar
• Gross, D.M.; Steere, A.C.; Huber, B.T. T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol. 1998, 160 (2):1022–1028.
   PubMedGoogle Scholar
• Shin, J.J.; Glickstein, L.J.; Steere, A.C. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory Lyme arthritis. Arthritis Rheum. 2007, 56 (4):1325–1335.
   PubMedGoogle Scholar